Global Antiviral Drugs Market: Global Size, Trends, Competitive, and Historical
The antiviral drugs market involves the global development, production and commercialization of drugs designed to prevent and treat viral infections by suppressing or eliminating viral replication within the body. Its scope includes a wide range of drug classes such as reverse transcriptase inhibitors, protease inhibitors, polymerase inhibitors, neuraminidase inhibitors, and combination therapies targeting diseases including HIV, hepatitis B and C, influenza, herpes, respiratory syncytial virus (RSV), and other emerging viral infections.